Laura Calabresi Selected Research

Laura Calabresi Research Topics

Disease

22	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 10/2023 - 06/2004
21	Atherosclerosis 03/2021 - 09/2002
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 02/2003
10	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2008
8	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 11/2013 - 02/2002
6	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 11/2017
6	Hypercholesterolemia 01/2022 - 09/2005
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2014
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 04/2003
4	Anemia 08/2022 - 07/2011
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 01/2018
4	Acute Coronary Syndrome 01/2019 - 10/2003
4	Coronary Disease (Coronary Heart Disease) 06/2016 - 06/2002
4	Amyloidosis 01/2015 - 05/2004
4	Ischemia 02/2008 - 02/2003
4	Reperfusion Injury 09/2006 - 02/2003
3	Chronic Renal Insufficiency 10/2023 - 07/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2019
3	Cholesteryl Ester Transfer Protein Deficiency 09/2022 - 02/2002
3	Corneal Opacity 08/2022 - 07/2011
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2021
3	Essential Thrombocythemia 01/2021 - 01/2019
3	Neoplasms (Cancer) 01/2021 - 11/2017
3	Myocardial Infarction 01/2021 - 02/2013
3	ST Elevation Myocardial Infarction 01/2019 - 01/2009
3	Familial Amyloidosis (Hereditary Amyloidosis) 01/2015 - 05/2004
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 05/2008 - 02/2004
3	Necrosis 02/2008 - 02/2003
3	Heart Neoplasms 02/2008 - 02/2003
3	Atherosclerotic Plaque (Atheroma) 12/2006 - 03/2006
2	Renal Insufficiency (Renal Failure) 07/2023 - 01/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 07/2023 - 09/2019
2	Fibrosis (Cirrhosis) 01/2023 - 01/2022
2	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2022 - 06/2004
2	Hypertension (High Blood Pressure) 08/2022 - 01/2018
2	Proteinuria 08/2022 - 01/2013
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2013
2	Homozygous Familial Hypercholesterolemia 01/2021 - 01/2017
2	Non-alcoholic Fatty Liver Disease 12/2020 - 12/2019
2	Inflammation (Inflammations) 11/2017 - 10/2017
2	Hypertriglyceridemia 11/2015 - 06/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2013 - 03/2004
2	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 05/2012 - 02/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2006 - 01/2004
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	2 Familial Hypobetalipoproteinemia 01/2023

Drug/Important Bio-Agent (IBA)

38	CholesterolIBA 11/2023 - 02/2002
28	LipidsIBA 01/2023 - 02/2003
27	HDL CholesterolIBA 11/2023 - 03/2006
25	HDL LipoproteinsIBA 11/2023 - 02/2003
16	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2023 - 02/2003
16	Lipoproteins (Lipoprotein)IBA 07/2023 - 02/2004
14	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 07/2023 - 06/2004
13	oxidized low density lipoproteinIBA 01/2022 - 04/2003
10	EnzymesIBA 01/2022 - 05/2006
8	ApolipoproteinsIBA 01/2021 - 09/2002
7	LDL CholesterolIBA 01/2020 - 08/2006
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2009
5	Apolipoproteins B (ApoB)IBA 10/2023 - 05/2012
5	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2005
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2005
4	Apolipoproteins E (ApoE)IBA 10/2023 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
3	Lipoprotein-XIBA 07/2023 - 01/2016
3	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022 - 10/2015
3	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2017 - 05/2004
3	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2015 - 09/2013
3	Fenofibrate (CiL)FDA LinkGeneric 11/2015 - 06/2010
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013 - 02/2005
3	Creatine Kinase (Creatine Phosphokinase)IBA 02/2008 - 02/2003
2	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 01/2013
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022 - 05/2004
2	CER-001IBA 01/2022 - 01/2021
2	Cholesterol Ester Transfer ProteinsIBA 03/2021 - 07/2012
2	red yeast riceIBA 01/2021 - 01/2014
2	BMS201038IBA 01/2021 - 01/2017
2	CalreticulinIBA 01/2021 - 01/2019
2	CytokinesIBA 01/2020 - 01/2016
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2019 - 10/2015
2	Blood Proteins (Serum Proteins)IBA 01/2019 - 05/2004
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019 - 03/2006
2	Cell Adhesion MoleculesIBA 01/2017 - 11/2007
2	Nonsense Codon (Nonsense Mutation)IBA 07/2012 - 04/2003
2	Amyloid (Amyloid Fibrils)IBA 06/2011 - 12/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008 - 02/2003
2	apolipoprotein A-I MilanoIBA 11/2007 - 02/2007
2	Apoprotein(a) (Apolipoprotein (a))IBA 09/2006 - 03/2006
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2004 - 02/2003
1	dapagliflozinIBA 10/2023
1	Protein Isoforms (Isoforms)IBA 10/2023
1	Apolipoprotein E3IBA 10/2023
1	Apolipoprotein E4IBA 10/2023
1	Apolipoprotein E2IBA 10/2023
1	romiplostim FDA Link 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	OsteopontinIBA 01/2023

Therapy/Procedure

9	Therapeutics 01/2023 - 02/2003
2	Blood Component Removal (Apheresis) 01/2021 - 01/2017
2	Injections 09/2006 - 03/2006